Organisation paid for research Program year 2022 Source: CMS Open Payments

Allergy Asthma and Sinus Cente

Neither a doctor nor a teaching hospital

Research payments

$160,670

23 payments

Through program year 2022, Allergy Asthma and Sinus Cente is reported as receiving $160,670 in research payments, across 23 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$85,428	15
2021	Research	$75,242	8

Breakdown

Who paid Research payments · program years 2021–2022

Regeneron Pharmaceuticals, Inc. $160,670 23 payments

Studies the money was for Research payments · program years 2021–2022

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy of Anti-Bet v 1 Monoclonal Antibodies to Reduce Symptoms of Seasonal Allergic Rhinitis $87,645 17 payments
A Randomized, Double-Blind, Placebo-Controlled Study in Cat-Allergic Patients With Allergic Rhinitis Who Live With a Cat to Assess the Efficacy and Safety of Anti-Fel d 1 Antibodies During Natural Cat Exposure in the Home $73,025 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.